1. Introduction
===============

Gorgonian corals have provided an abundance of novel structures with many of these demonstrating potentially useful biological activities. The gorgonian *Briareum asbestinum* has shown to be a plentiful source of diterpenoids belonging to the eunicellin, asbestinane, cembrane, and briarane classes and display numerous biological activities (e.g., cytotoxicity, antimicrobial, anti-inflammatory, antiviral, immunomodulatory, antifouling, and ichthotoxicity) \[[@B1-marinedrugs-10-01662]\]. Briarane-type diterpenoids contain a highly oxidized bicyclo\[8.4.0\] system of which most contain a γ-lactone ring. The briareolate esters are a small group of briarane diterpenoids isolated from *Briareum asbestinum* that contain a C-19 methyl ester instead of the typical γ-lactone ring \[[@B2-marinedrugs-10-01662],[@B3-marinedrugs-10-01662],[@B4-marinedrugs-10-01662]\].

As part of an ongoing study to discover compounds that impact human embryonic stem cell (hESC) growth we have been screening pre-fractionated and semi-purified marine natural product extract libraries generated using a solid phase extraction (SPE) procedure followed by semi-preparative high pressure liquid chromatography (HPLC) using evaporative light scattering detection (ELSD) directed fractionation ([Figure 1](#marinedrugs-10-01662-f001){ref-type="fig"}). The cell growth inhibitory activities of the pre-fractionated extract libraries are then evaluated against human embryonic stem cells (BG02) using a 96-well plate real-time cell electronic sensing (RT-CES) system to identify compounds that impact self-renewal, differentiation or apoptosis. A plot of cell index (impedance) *versus* time is used to indicate relative proliferation, differentiation, or death in real-time ([Figure 2](#marinedrugs-10-01662-f002){ref-type="fig"}).

Our previous work using this approach on *B. asbestinum* resulted in the isolation of three new briareolate esters L--N (**3**--**5**) \[[@B5-marinedrugs-10-01662]\]. This included the biologically active compound briareolate ester L (**3**) that was found to possess a 10-membered macrocyclic ring with a (*E*,*Z*)-dieneone and was shown to contain a "spring loaded" Michael acceptor that is capable of forming a reversible covalent bond to model sulfur-based nucleophiles. In the present study we report the isolation and structural elucidation of two additional new briarane diterpenoids briareolate esters J (**1**) and K (**2**), along with three known compounds from the methanolic extract of *B. asbestinum* that was found to exhibit growth inhibition against BG02 cells ([Figure 3](#marinedrugs-10-01662-f003){ref-type="fig"}).

![HPLC chromatogram of the pre-fractionated extract of *B. asbestinum* showing the fractions separated using ELSD-directed collection to generate a semi-purified extract library for biological screening.](marinedrugs-10-01662-g001){#marinedrugs-10-01662-f001}

![A cell index *vs.* time plot for a pre-fractionated extract library of *B. asbestinum* against the BG02 cell line. A drop in cell index within the first 24--48 h after addition of the compounds is interpreted as toxicity or induction of apoptosis.](marinedrugs-10-01662-g002){#marinedrugs-10-01662-f002}

![Structures of compounds **1**--**7**.](marinedrugs-10-01662-g003){#marinedrugs-10-01662-f003}

2. Results and Discussion
=========================

Specimens of *Briareum asbestinum* ([Figure 4](#marinedrugs-10-01662-f004){ref-type="fig"}) were collected at Hillsboro Ledge, Boca Raton Florida and kept frozen until extraction. The methanolic extract was first fractionated on polymeric HP-20 resin using cyclic loading \[[@B6-marinedrugs-10-01662]\]. The HP-20 column was eluted with 800 mL fractions of (1) H~2~O, (2) 40% Me~2~CO/H~2~O, (3) 75% Me~2~CO/H~2~O and (4) Me~2~CO. The Me~2~CO fraction was then subjected to column chromatography on HP-20SS and normal phase HPLC to yield two new briareolate esters J (**1**) and K (**2**) and three known briareolate esters D (**6**), G (**7**), and M (**4**).

![*Briareum asbestinum*.](marinedrugs-10-01662-g004){#marinedrugs-10-01662-f004}

Briareolate ester J (**1**) was isolated as a colorless oil. The molecular formula of briareolate ester J (**1**), C~33~H~50~O~9~, was determined from the HRESIMS of the \[M + Na\]^+^ ion at *m*/*z* 613.3346, 98 mass units higher than that of briareolate ester G (**7**). The presence of a ketone conjugated with two double bonds (α,β,γ,δ-unsaturated ketone) was indicated from a carbonyl carbon with a chemical shift of δ~C~ 207 (C-9), and the C-C double bond carbons \[δ~C~ 146.3 (C-5), δ~C~ 125.3 (C-6), δ~C~ 140.9 (C-7), δ~C~ 146.3 (C-8)\]. The observation of absorption maxima at λ~max~ = 287 and 225 nm in the UV spectrum was consistent with this assignment. NOE correlations observed from the olefinic proton H-6 to H-7 and H~3~-16, together with correlations from H-7 to both H-17 and H~3~-18, established the (*Z*,*Z*)-configuration of the dieneone and the *s*-*cis* conformation of the diene ([Figure 5](#marinedrugs-10-01662-f005){ref-type="fig"}). Additionally, the upfield chemical shift of the olefinic proton H-7 in **1**at δ~H~ 6.74 compared toδ~H~ 7.64 in the (*E*,*Z*)-dieneone briareolate ester L (**3**), with the *s*-*trans* diene conformation, confirmed this assignment \[[@B5-marinedrugs-10-01662]\].

A close inspection of the ^1^H and ^13^C NMR data ([Table 1](#marinedrugs-10-01662-t001){ref-type="table"}) revealed the similarity of **1** to that of briareolate ester G (**7**), except that H-12 \[δ~H~ 4.89, br s\] was shifted downfield by 1.24 ppm as compared with that of **1**. In addition, in the ^13^C NMR spectrum the resonance of C-12 (δ~C~ 73.7) was shifted downfield by 2.7 ppm and those of C-11 (δ~C~ 38.4) and C-13 (δ~C~ 30.2) were shifted upfield by 0.5 and 1.3 ppm, respectively, in comparison with those of **1** \[[@B4-marinedrugs-10-01662]\]. This suggested that the 12-hydroxy group of **7**, was replaced by a hexanoate group at C-12 in **1**, as observed in briareolate esters M (**4**) and N (**5**). The presence of the hexanoate group was confirmed by the NMR data \[δ~H~ 0.92 (3H, t, *J* = 8.0 Hz), *ca.* 1.31 (4H, overlapped), 1.63 (2H, overlapped), 2.32 (2H, m), δ~C~ 17.6 (q), 24.0, 26.3, 33.0, and 36.1 (each t), 175.1 (CO)\]. These assignments were confirmed by COSY, HSQC, and HMBC correlations similar to those observed for **4**, **5** and **7** ([Figure 5](#marinedrugs-10-01662-f005){ref-type="fig"}). The relative configuration of briareolate ester J (**1**) was determined to be the same as that of **7** from the similarity of proton-proton coupling constants and ^1^H and ^13^C chemical shifts together with NOE correlations observed in a ROESY experiment ([Figure 5](#marinedrugs-10-01662-f005){ref-type="fig"}).

marinedrugs-10-01662-t001_Table 1

###### 

NMR Spectroscopic Data for Briareolate Esters J (**1**) and K (**2**) ^a^.

  position        1             2                                
  --------------- ------------- ------------------ ------------- ----------------------
  1               46.4, C                          48.8, C       
  2               73.7, CH      5.17, br d (6.0)   80.5, CH      5.52, d (8.0)
  3α              31.3, CH~2~   1.89, m            31.1, CH~2~   2.31, m
  3β                            1.89, m                          1.58, m
  4α              30.2, CH~2~   2.20, m            34.1, CH~2~   2.53, dd (18.0, 8.0)
  4β                            2.08, m                          2.28, m
  5               146.3, C                         147.1, C      
  6               125.3, CH     6.12, br s         116.2, CH     5.47, br d (4.0)
  7               140.9, CH     6.74, br s         64.3, CH      4.42, br d (4.0)
  8               146.3, C                         71.3, C       
  9               207.0, C                         211.5, C      
  10              48.3, CH      3.79, d (12.0)     44.7, CH      3.06, d (12.0)
  11              38.4, CH      2.19, m            36.2, CH      2.34, m
  12              73.7, CH      4.89, br s         72.6, CH      4.98, br s
  13α             30.2,CH~2~    2.05, m            29.9, CH~2~   2.05, br d (16.0)
  13β                           1.86, m                          1.99, m
  14              75.6, CH      4.68, br s         74.6, CH      4.69, br s
  15              14.9, CH~3~   1.19, s            12.8, CH~3~   0.99, s
  16              26.3, CH~3~   2.19, s            26.8, CH~3~   1.75, s
  17              46.4, CH      3.45, q (8.0)      40.8, CH      2.39, q (8.0)
  18              19.8, CH~3~   1.32, d (8.0)      13.5, CH~3~   1.29, d (8.0)
  19              176.7, C                         175.3, C      
  20              17.6, CH~3~   0.79, d (8.0)      16.8, CH~3~   0.75, d (8.0)
  OMe             52.8, CH~3~   3.62, s            52.5, CH~3~   3.61, s
  ester at C-2    175.1, C                         174.3, C      
                  37.7, CH~2~   2.19, m            37.9, CH~2~   2.25, m
                  19.2, CH~2~   1.57, m            19.7, CH~2~   1.60, m
                  14.5, CH~3~   0.92, t (8.0)      14.5, CH~3~   0.93, t (8.0)
  ester at C-12   175.1, C                         175.4, C      
                  36.1, CH~2~   2.32, m            35.9 CH~2~    2.37, m
                  26.3, CH~2~   1.63, m            26.4 CH~2~    1.64, m
                  33.0, CH~2~   1.31, m            33.0 CH~2~    1.33, m
                  24.0, CH~2~   1.31, m            24.0 CH~2~    1.33, m
                  17.6, CH~3~   0.92, t (8.0)      14.8 CH~3~    0.95, t (8.0)
  ester at C-14   172.1, C                         172.6, C      
                  22.1, CH~3~   1.98, s            22.3 CH~3~    1.99, s

^a^ In CD~3~OD, 400 MHz for ^1^H and 100 MHz for ^13^C NMR.

![Selected 2D NMR correlations for briareolate ester J (**1**).](marinedrugs-10-01662-g005){#marinedrugs-10-01662-f005}

Briareolate ester K (**2**) was isolated as a colorless oil. The molecular formula of briareolate ester K (**2**), C~33~H~50~O~10~, was determined from the HRESIMS of the \[M + Na\]^+^ ion at *m*/*z* 629.3291, one more oxygen atom than that of briareolate ester J (**1**). A comparison of the ^1^H and ^13^C NMR data ([Table 1](#marinedrugs-10-01662-t001){ref-type="table"}) revealed that **2** was similar to **1**, except that the NMR signals for the C-7--C-8 double bond were missing in the NMR spectra of **2**, and instead, resonances for an epoxide were observed in the ^1^H NMR (δ 4.42, H-6) and ^13^C NMR \[δ~C~ 64.3 (s); 71.3 (d)\] spectra indicating oxidation of the C-7--C-8 double bond to be an epoxide. HMBC correlations from the oxygenated methine signal at δ 4.42 (H-7) to C-5 (δ 147.1) and C-6 (δ 116.2) of the trisubstituted double bond, and to C-8 (δ 71.3) and C-9 (δ 211.5) are consistent with this assignment. Additional HMBC correlations observed from H-17 to C-7, C-8 and C-9 confirmed this assignment ([Figure 6](#marinedrugs-10-01662-f006){ref-type="fig"}).

![Selected NMR correlations for briareolate ester K (**2**).](marinedrugs-10-01662-g006){#marinedrugs-10-01662-f006}

The relative configuration of briareolate ester K (**2**) was determined to be identical to that of **1** on the basis of NOE enhancements revealed in a series of 1D NOESY experiments ([Figure 6](#marinedrugs-10-01662-f006){ref-type="fig"}). The configuration of the C-7/8 epoxide was determined from NOE enhancements observed between H-7 and H-2 together with NOE enhancements observed from H-6 to H-17 which placed H-7 on the inside of the 10-membered ring and indicated the *trans* orientation of the epoxide. This assignment is consistent with that of briareolate ester D (**6**) whose structure was assigned on the basis of X-ray crystallography \[[@B4-marinedrugs-10-01662]\].

Compounds **1** and **2** were evaluated for cell growth inhibitory activities against human embryonic stem cells (BG02) using a 96-well plate real-time cell electronic sensing (RT-CES) system \[[@B7-marinedrugs-10-01662]\]. Briareolate ester K (**2**) showed weak growth inhibition against BG02 cells with an EC~50~ value of 40 µM. No inhibitory activity was detected for briareolate ester J (**1**) at 40 µM. Previously the (*E*,*Z*)-dienone containing briareolate esters L (**3**) and M (**4**) were found to have growth inhibition against both the BG02 and a pancreatic cancer cell line (BxPC-3) cells with EC~50~ values of 2.4 and 9.3 µM, respectively for **3**, and 8.0 µM against BG02 cells and only cytostatic effects at 13.0 and 17.0 µM against the BxPC-3 cells for **4**\[[@B5-marinedrugs-10-01662]\]. No growth inhibition was found for the briareolate esters B, C, G (**7**), and N (**5**). The absence of significant growth inhibition activity for the (*Z*,*Z*)-dieneone compound **1** and the epoxide containing compound **2** further confirms the importance of the (*E*,*Z*)-dieneone for biological activity.

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotations were measured on a Jasco P-2000 polarimeter (*c*: g/100 mL) at 589 nm. UV spectra were obtained on a Perkin-Elmer Lambda EZ 210 UV-vis spectrophotometer. IR spectra were recorded on a Thermo Electronic Corporation Nicolet IR-100 spectrophotometer. All NMR spectra were recorded on a Varian MercuryPlus 400 spectrometer. All chemical shifts (δ) were referenced internally to the residual solvent peak (CD~3~OD: ^1^H, δ 3.30; ^13^C, δ 49.0; CDCl~3~: ^1^H 7.26 ppm; ^13^C 77.0 ppm). Short- and long-range ^1^H--^13^C correlations were determined with gradient-enhanced inverse-detected HSQC and HMBC experiments respectively. NOE correlations were detected with NOESY or ROESY experiments with a 0.5 s mixing time. The high-resolution ESI mass spectra were obtained using an Agilent 6210 LC-TOF mass spectrometer at the Mass Spectrometer Facility at the University of Florida, Gainesville, Florida. HPLC purifications were performed on Beckman System Gold HPLC system with a 168 UV detector and a SEDEX 85 (Sedere) evaporative light scattering detector. Thin layer chromatography (TLC) analyses were performed using Merck Kieselgel (Aufoilen) 60 F~254~ plates. TLC plates were visualized by spraying with 1:1 MeOH:H~2~SO~4~.

3.2. Animal Material
--------------------

The gorgonian *Briareum asbesinum* was collected by hand using SCUBA at a depth of 45--50 ft from Hillsboro Ledge, Boca Raton Florida. The specimen was immediately frozen and kept at −20 °C until extraction. A voucher specimen has been deposited in the Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton Florida (FAU02-010).

3.3. Extraction and Isolation
-----------------------------

The sample of *Briareum asbestinum* (500 g wet wt.), were extracted with MeOH (3 × 800 mL) for 24 h. The third, second and then the first extracts were passed through a column of HP-20 resin (2.5 × 25 cm) equilibrated with MeOH. The combined eluents was diluted with H~2~O (2.5 L) and passed again through the column. The column was eluted with 800 mL fractions of: (1) H~2~O, (2) 40% Me~2~CO/H~2~O, (3) 75% Me~2~CO/H~2~O and (4) Me~2~CO. Fraction 4 was concentrated to dryness and was subjected to column chromatography on HP-20SS resin eluting with increasing concentrations of MeCN in H~2~O (40%--100%). A late eluting fraction was further subjected to semi-preparative silica gel HPLC (Luna 5 µm; 10 × 250 mm; 4 mL/min; 5%--50% EtOAc/Hexane over 30 min) to give **1** (6.0 mg), **2** (10.0 mg), **4** (10.0 mg), **6** (10.0 mg) and **7** (5.0 mg).

Briareolate ester J (**1**): Colorless oil; \[α\]^25^~D~ −19 (*c* 0.05, MeOH); UV (MeOH) λ~max~ 225 nm (ε 2711), 287 (ε 1713); IR (MeOH) ν~max~ 2956, 2867, 1737, 1641, 1454, 1371 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-10-01662-t001){ref-type="table"}; HRESIMS *m/z* 613.3346 \[M + Na\]^+^ (calcd. for C~33~H~50~O~9~Na, 613.3353).

Briareolate ester K (**2**): Colorless oil; \[α\]^25^~D~ −8 (*c* 0.05, MeOH); IR (MeOH) ν~max~ 2951, 2869, 1742, 1454, 1367 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-10-01662-t001){ref-type="table"}; HRESIMS *m/z* 629.3291 \[M + Na\]^+^ (calcd. for C~33~H~50~O~10~Na, 629.3302).

3.4. Cell Culture
-----------------

BG02 hESCs were grown in defined medium, containing 10 ng/mL HRG1β (Peprotech), 10 ng/mL ActA (R&D Systems), 200 ng/mL LR^3^-IGF1 (JRH Biosciences), and 8 ng/mL FGF2 (Sigma or R&D Systems). Cultures were passaged with Accutase (Innovative Cell Technologies) and plated on tissue culture flasks coated with growth factor-reduced matrigel (BD Biosciences) diluted 1:200, as described by Robins and Schulz \[[@B8-marinedrugs-10-01662]\].

3.5. RT-CES Cytotoxicity Assays
-------------------------------

The xCELLigence real-time impedance system (Roche) was used to monitor the effects of compounds on cells \[[@B7-marinedrugs-10-01662]\]. BG02 cells were plated at 1 × 10^4^ cells/well in matrigel coated plates. The culture was placed in the reader station under standard humidified conditions and incubated at 37 °C with 5% CO~2~. The media was changed every 24 h and impedance was measured every 15 min for 3 days. Compounds were added to quadruplicate wells 24 h after plating. Vincristine was used as a positive control for cytotoxicity, and DMSO alone was used as a negative control. Cell index plots were normalized immediately prior to addition of compound, and EC~50~ values were generated using the xCELLigence analysis software RTCA ver 1.1 after 2 days of treatment.

4. Conclusions
==============

Two new briarane diterpenoids briareolate esters J (**1**) and K (**2**), along with three known compounds were isolated from the methanolic extract of *B. asbestinum* collected off the coast of Boca Raton, Florida. The compounds were identified from screening semi-purified and pre-fractioned extract libraries against hESCs and briareolate ester K (**2**) containing a *trans* C-7/8 epoxide was found to exhibit weak growth inhibition activity against human embryonic stem cells (BG02). The lack of biological activity for briaranes **1** and **2** further confirmed the requirement of the α,β,γ,δ-unsaturated ketone in conjunction with the double bond configuration for biological activity.
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